Treating Cancer


NCI’s commitment to developing new treatments for cancer patients spans basic research to discover the mechanisms of cancer, preclinical research to investigate the anticancer effects of therapies that target these mechanisms, and clinical research to test new therapies in patients. Despite recent advances in targeted therapy and immunotherapy, more needs to be done to substantially improve the outlook for both adults and children with cancer. Three areas for further investment include developing combination therapies, biomarker-guided immunotherapies, and precision medicines that target specific abnormalities in a patient’s cancer.